Biopolar Hongye

Biopolar Hongye (Beijing) Pharmaceutical Co., Ltd. is a specialized biopharmaceutical company based in China that focuses on the development, manufacturing, and commercialization of cardiovascular and antithrombotic therapies. The company is recognized for its expertise in complex generic drugs, particularly synthetic peptides and small molecule anticoagulants used in surgical and critical care settings. Its flagship products include Bivalirudin and Argatroban, which are widely utilized in percutaneous coronary interventions and the management of heparin-induced thrombocytopenia. Biopolar Hongye operates advanced GMP-certified facilities in Beijing and maintains a robust R&D pipeline aimed at expanding its portfolio in the vascular medicine space. The company originated from the commercialization initiatives of the Chinese Academy of Sciences, ensuring a strong foundation in biophysical research and high-quality production standards.